Literature DB >> 27758091

Global programme to eliminate lymphatic filariasis: progress report, 2015.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27758091

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  41 in total

1.  Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.

Authors:  Jennifer S F da Silva; Cynthia Braga; Felipe M Duarte; Paula Oliveira; Carlos Feitosa Luna; Márcia Marcondes; Josué Araújo; Maria Rosangela Grilis; Paula Fernanda A de Souza Melo; Eduardo Brandão; Abraham Rocha
Journal:  Pathog Glob Health       Date:  2018-08-15       Impact factor: 2.894

2.  Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.

Authors:  Nikhil Chauhan; Priyankana Banerjee; Vishal K Khatri; Andrew Canciamille; Jessica Gilles; Ramaswamy Kalyanasundaram
Journal:  Parasitol Res       Date:  2017-08-21       Impact factor: 2.289

3.  Filarial breast lump.

Authors:  Dwijesh Kumar Panda; Devi Prasad Mohapatra; Madhusmita Mohanty Mohapatra
Journal:  BMJ Case Rep       Date:  2017-08-23

4.  Bacterial diversity significantly reduces toward the late stages among filarial lymphedema patients in the Ahanta West District of Ghana: A cross-sectional study.

Authors:  Samuel O Asiedu; Priscilla Kini; Bill C Aglomasa; Emmanuel K A Amewu; Ebenezer Asiedu; Solomon Wireko; Kennedy G Boahen; Afiat Berbudi; Augustina A Sylverken; Alexander Kwarteng
Journal:  Health Sci Rep       Date:  2022-07-20

5.  Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.

Authors:  Cara L Macfarlane; Shyam S Budhathoki; Samuel Johnson; Marty Richardson; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2019-01-08

6.  Mansonella perstans microfilaremic individuals are characterized by enhanced type 2 helper T and regulatory T and B cell subsets and dampened systemic innate and adaptive immune responses.

Authors:  Manuel Ritter; Winston Patrick Chounna Ndongmo; Abdel Jelil Njouendou; Nora Nganyewo Nghochuzie; Lucy Cho Nchang; Dizzle Bita Tayong; Kathrin Arndts; Norman Nausch; Marc Jacobsen; Samuel Wanji; Laura E Layland; Achim Hoerauf
Journal:  PLoS Negl Trop Dis       Date:  2018-01-11

7.  Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.

Authors:  Ramakrishna U Rao; Sandhya D Samarasekera; Kumara C Nagodavithana; Tharanga D M Dassanayaka; Manjula W Punchihewa; Udaya S B Ranasinghe; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2017-10-30

8.  Supervision and support in surgical practice using mobile platform: a case of mass hydrocele surgeries in remote regions.

Authors:  Larry Akoko; Ally Mwanga; Maria Chikawe; Evelyne Lutainulwa; Deogratius Ngoma; Andreas Nshalla; Upendo Mwingira
Journal:  Mhealth       Date:  2019-09-24

9.  Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals.

Authors:  Veenu Bala; Yashpal S Chhonker; Abdullah Alshehri; Constant Edi; Catherine M Bjerum; Benjamin G Koudou; Christopher L King; Daryl J Murry
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.938

Review 10.  Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs.

Authors:  Lukyn M Gedge; Alison A Bettis; Mark H Bradley; T Déirdre Hollingsworth; Hugo C Turner
Journal:  Parasit Vectors       Date:  2018-02-01       Impact factor: 4.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.